Table 3.
Changes in Psychiatric Symptoms of Patients in Betahistine and Placebo Groups at Baseline and 4 Weeks Later
| Items | Betahistine Group | Placebo Group | Group×Time Interaction | |||
|---|---|---|---|---|---|---|
| Baseline | Week 4 | Baseline | Week 4 | F | p | |
| PANSS-positive symptom scores | 17.43 ± 5.22 | 17.49 ± 5.09 | 18.00 ± 5.03 | 18.68 ± 4.92 | 2.82 | 0.09 |
| PANSS-negative symptom scores | 22.45 ± 7.73 | 21.43 ± 7.04 | 23.04 ± 7.27 | 22.64 ± 6.70 | 3.11 | 0.08 |
| PANSS-general psychopathological symptom scores | 34.70 ± 6.94 | 34.11 ± 6.74 | 33.81 ± 6.47 | 33.47 ± 6.60 | 0.80 | 0.37 |
| PANSS total scores | 74.57± 14.20 | 73.23± 13.25 | 74.85± 13.64 | 74.79± 13.33 | 3.09 | 0.08 |
Abbreviation: PANSS, Positive and Negative Syndrome Scale.